Cargando…

Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder

Detalles Bibliográficos
Autores principales: Zarra, Julio, Schmidt, Luisa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992016/
http://dx.doi.org/10.1186/1744-859X-9-S1-S99
_version_ 1782192693070266368
author Zarra, Julio
Schmidt, Luisa
author_facet Zarra, Julio
Schmidt, Luisa
author_sort Zarra, Julio
collection PubMed
description
format Text
id pubmed-2992016
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29920162010-11-26 Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder Zarra, Julio Schmidt, Luisa Ann Gen Psychiatry Meeting Abstract BioMed Central 2010-04-22 /pmc/articles/PMC2992016/ http://dx.doi.org/10.1186/1744-859X-9-S1-S99 Text en Copyright ©2009 Zarra and Schmidt; licensee BioMed Central Ltd.
spellingShingle Meeting Abstract
Zarra, Julio
Schmidt, Luisa
Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
title Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
title_full Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
title_fullStr Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
title_full_unstemmed Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
title_short Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
title_sort long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992016/
http://dx.doi.org/10.1186/1744-859X-9-S1-S99
work_keys_str_mv AT zarrajulio longtermefficacyandsafetyofgalantamineinoutpatientswithmildcognitivedisorder
AT schmidtluisa longtermefficacyandsafetyofgalantamineinoutpatientswithmildcognitivedisorder